[Acute and sustained hemodynamic effects of a new inotropic agent TA-064 (Denopamine) in patients with refractory heart failure with special reference to dose-response effects].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged
D002316:Cardiotonic Agents; D004983:Ethanolamines; C037293:denopamine